3 Cash-Producing Stocks Skating on Thin Ice
Revvity is gearing up to announce its first-quarter results later this month, and analysts expect a single-digit drop in earnings.
1 Healthcare Stock to Target This Week and 2 to Turn Down
Nordson has notably underperformed the Dow over the past year, yet analysts remain optimistic about the stock’s prospects.
Despite lagging behind the Nasdaq Composite over the past year, analysts remain bullish on Revvity’s prospects.
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
3 Reasons to Sell RVTY and 1 Stock to Buy Instead
Investors in Revvity, Inc. RVTY need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $80 Call had some of the highest implied volatility...
Revvity has lagged behind the broader market this year, and Wall Street analysts maintain a cautiously optimistic outlook on its future potential.
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations